Researchers at The Kids Research Institute Australia are working with boys and young men in regional areas to help stamp out technology-based abuse o…
Understanding the distribution and variation in NMR-based inflammatory markers is crucial to the evaluation of their clinical utility in disease prog…
Nirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During…
Diarrhoea remains a leading cause of mortality among children under five years of age, with over 99 % of deaths occurring in low- and middle-income c…
The identification of a COPD etiotype associated with preterm birth (COPD-developmental) has expedited calls for intervention strategies that may imp…
International guidelines recommend multidisciplinary intervention programs for addressing childhood obesity. In Western Australia, community-based he…
Children living with a rare disease often endure a lengthy journey to diagnosis, commonly referred to as a diagnostic odyssey. This journey significa…
Azithromycin improves symptomology in various chronic airway diseases exacerbated by viral infections. However, the mechanisms underlying the apparen…
Researchers from The Kids Research Institute Australia have contributed to a landmark study revealing climate change will have a detrimental impact o…
Clostridioides (Clostridium) difficile transmission between community and healthcare settings has been increasingly reported. We aimed to identify th…